Tapewire

NYSE · USD

HCA

HCA Healthcare, Inc.

Export transactions ↓
Tapewire entity
2929
SEC CIK
0000860730
Parsed reports
883

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 2026012
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 25, 2022 Filed Apr 27, 2022 18:34 UTC GrantCommon Stock 902 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025876 · doc4.xml · nonDerivative · entry 1

Riley Wayne Joseph · CIK 0001432895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,602

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 18:33 UTC GrantCommon Stock 1,424 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025875 · doc4.xml · nonDerivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,200

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 522 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 18:30 UTC GrantCommon Stock 902 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025872 · doc4.xml · nonDerivative · entry 1

HOLLIDAY CHARLES O JR · CIK 0001127289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,955

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 18:21 UTC
Frist William RDirector · 10% owner
GrantCommon Stock, par value $0.01 per share 1,424 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025863 · doc4.xml · nonDerivative · entry 1

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,895

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 522 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 18:19 UTC
FRIST THOMAS F IIIDirector · 10% owner
GrantCommon Stock, par value $0.01 per share 1,899 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025855 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,817

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 997 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 18:20 UTC GrantCommon Stock 902 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025858 · doc4.xml · nonDerivative · entry 1

DEPARLE NANCY ANN · CIK 0001144511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,483

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 18:19 UTC GrantCommon Stock 902 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025854 · doc4.xml · nonDerivative · entry 1

Dennis Robert J · CIK 0001295441 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,565

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

Read SEC document
April 25, 2022 Filed Apr 27, 2022 18:18 UTC
CROFTON MEGDirector
GrantCommon Stock 902 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025851 · doc4.xml · nonDerivative · entry 1

CROFTON MEG · CIK 0001665104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,058

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 18:33 UTC
Sowell Joseph A IIISVP; Chief Development Officer
SaleCommon Stock 11,522 $269.00 $3,099,418.00
Disclosure

SEC source: 0001209191-22-018943 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,051

F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:15 UTC
Foster Jon MGroup President
Tax withholdingCommon Stock 6,082 $244.10 $1,484,616.20
Disclosure

SEC source: 0001209191-22-012405 · doc4.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,938

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:15 UTC
Foster Jon MGroup President
GrantCommon Stock 17,020 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012405 · doc4.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,020

F1 · kind: On January 30, 2019, the reporting person was granted 8,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:22 UTC
Wyatt Christopher F.SVP & Controller
Tax withholdingCommon Stock 1,836 $244.10 $448,167.60
Disclosure

SEC source: 0001209191-22-012425 · doc4.xml · nonDerivative · entry 2

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,184

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:22 UTC
Wyatt Christopher F.SVP & Controller
GrantCommon Stock 6,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012425 · doc4.xml · nonDerivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,020

F1 · kind: On January 30, 2019, the reporting person was granted 3,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:21 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
Tax withholdingCommon Stock 1,224 $244.10 $298,778.40
Disclosure

SEC source: 0001209191-22-012423 · doc4.xml · nonDerivative · entry 3

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,873

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:21 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
GrantCommon Stock 4,640 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012423 · doc4.xml · nonDerivative · entry 2

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,097

F1 · kind: On January 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:21 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
Tax withholdingCommon Stock 1,836 $244.10 $448,167.60
Disclosure

SEC source: 0001209191-22-012422 · doc4.xml · nonDerivative · entry 2

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,372

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:21 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
GrantCommon Stock 6,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012422 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,208

F1 · kind: On January 30, 2019, the reporting person was granted 3,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:20 UTC
Sowell Joseph A IIISVP; Chief Development Officer
Tax withholdingCommon Stock 3,046 $244.10 $743,528.60
Disclosure

SEC source: 0001209191-22-012420 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,573

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:20 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GrantCommon Stock 7,740 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012420 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,619

F1 · kind: On January 30, 2019, the reporting person was granted 3,870 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:20 UTC Tax withholdingCommon Stock 8,821 $244.10 $2,153,206.10
Disclosure

SEC source: 0001209191-22-012419 · doc4.xml · nonDerivative · entry 2

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,968

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:20 UTC GrantCommon Stock 23,980 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012419 · doc4.xml · nonDerivative · entry 1

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,789

F1 · kind: On January 30, 2019, the reporting person was granted 11,990 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:19 UTC
Reiner Deborah MSVP - Mktg. & Communications
Tax withholdingCommon Stock 1,223 $244.10 $298,534.30
Disclosure

SEC source: 0001209191-22-012417 · doc4.xml · nonDerivative · entry 2

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,941

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:19 UTC
Reiner Deborah MSVP - Mktg. & Communications
GrantCommon Stock 4,640 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012417 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,164

F1 · kind: On January 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:18 UTC Tax withholdingCommon Stock 3,046 $244.10 $743,528.60
Disclosure

SEC source: 0001209191-22-012415 · doc4.xml · nonDerivative · entry 2

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,112

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:18 UTC GrantCommon Stock 9,280 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012415 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,158

F1 · kind: On January 30, 2019, the reporting person was granted 4,640 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:17 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Tax withholdingCommon Stock 229 $244.10 $55,898.90
Disclosure

SEC source: 0001209191-22-012413 · doc4.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,421

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:17 UTC
Mosier Sammie SSVP & Chief Nurse Executive
GrantCommon Stock 940 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012413 · doc4.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,650

F1 · kind: On January 30, 2019, the reporting person was granted 470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:17 UTC
MOORE A BRUCE JRGroup President - Service Line
Tax withholdingCommon Stock 3,656 $244.10 $892,429.60
Disclosure

SEC source: 0001209191-22-012411 · doc4.xml · nonDerivative · entry 2

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,972

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:17 UTC
MOORE A BRUCE JRGroup President - Service Line
GrantCommon Stock 10,840 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012411 · doc4.xml · nonDerivative · entry 1

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,628

F1 · kind: On January 30, 2019, the reporting person was granted 5,420 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:16 UTC
HAZEN SAMUEL NDirector · CEO
Exercise / conversionRestricted Stock Units · Derivative 6,011 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012408 · doc4.xml · derivative · entry 5

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,011 shares

Expires 2022-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:16 UTC
HAZEN SAMUEL NDirector · CEO
Tax withholdingCommon Stock 35,830 $244.10 $8,746,103.00
Disclosure

SEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 3

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 378,885

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:16 UTC
HAZEN SAMUEL NDirector · CEO
Exercise / conversionCommon Stock 6,011 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:16 UTC
HAZEN SAMUEL NDirector · CEO
GrantCommon Stock 85,040 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408,704

F1 · kind: On January 30, 2019, the reporting person was granted 42,520 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:16 UTC
Hall Charles JGroup President
Tax withholdingCommon Stock 6,082 $244.10 $1,484,616.20
Disclosure

SEC source: 0001209191-22-012407 · doc4.xml · nonDerivative · entry 2

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,638

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:16 UTC
Hall Charles JGroup President
GrantCommon Stock 17,020 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012407 · doc4.xml · nonDerivative · entry 1

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,720

F1 · kind: On January 30, 2019, the reporting person was granted 8,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:14 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
Tax withholdingCommon Stock 3,658 $244.10 $892,917.80
Disclosure

SEC source: 0001209191-22-012404 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,143.706

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:14 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
GrantCommon Stock 10,840 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012404 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,801.706

F1 · kind: On January 30, 2019, the reporting person was granted 5,420 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:14 UTC
Cohen Jeffrey E.SVP-Government Relations
Tax withholdingCommon Stock 1,634 $244.10 $398,859.40
Disclosure

SEC source: 0001209191-22-012402 · doc4.xml · nonDerivative · entry 2

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,006

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:14 UTC
Cohen Jeffrey E.SVP-Government Relations
GrantCommon Stock 4,640 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012402 · doc4.xml · nonDerivative · entry 1

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,640

F1 · kind: On October 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:13 UTC
Billington Phillip GSVP-Internal Audit Services
Tax withholdingCommon Stock 1,224 $244.10 $298,778.40
Disclosure

SEC source: 0001209191-22-012401 · doc4.xml · nonDerivative · entry 2

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,525.427

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:13 UTC
Billington Phillip GSVP-Internal Audit Services
GrantCommon Stock 4,640 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012401 · doc4.xml · nonDerivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,749.427

F1 · kind: On January 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:13 UTC
Berres JenniferSVP & Chief Human Res. Officer
Tax withholdingCommon Stock 2,827 $244.10 $690,070.70
Disclosure

SEC source: 0001209191-22-012400 · doc4.xml · nonDerivative · entry 3

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,750

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:13 UTC
Berres JenniferSVP & Chief Human Res. Officer
GrantCommon Stock 6,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012400 · doc4.xml · nonDerivative · entry 2

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,577

F2 · kind: On October 30, 2019, the reporting person was granted 3,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 19:13 UTC
Berres JenniferSVP & Chief Human Res. Officer
GrantCommon Stock 2,520 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012400 · doc4.xml · nonDerivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,377

F1 · kind: On January 30, 2019, the reporting person was granted 1,260 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 17, 2022 Filed Feb 18, 2022 18:47 UTC
MOORE A BRUCE JRGroup President - Service Line
SaleCommon Stock 9,367 $253.18 $2,371,502.40
Disclosure

SEC source: 0001209191-22-011461 · doc4.xml · nonDerivative · entry 2

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,788

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.10 to $253.45, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 18:47 UTC
MOORE A BRUCE JRGroup President - Service Line
SaleCommon Stock 20,633 $244.01 $5,034,685.15
Disclosure

SEC source: 0001209191-22-011461 · doc4.xml · nonDerivative · entry 1

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,155

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.00 to $244.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 09, 2022 Filed Feb 23, 2022 19:21 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
GiftCommon Stock 420 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012423 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,457

Read SEC document
February 03, 2022 Filed Feb 7, 2022 18:45 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Exercise / conversionRestricted Stock Units · Derivative 137 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007602 · doc4.xml · derivative · entry 3

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413

Underlying: Common Stock · 137 shares

Expires 2031-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning February 3, 2022.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 18:45 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Tax withholdingCommon Stock 34 $240.86 $8,189.24
Disclosure

SEC source: 0001209191-22-007602 · doc4.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,710

Read SEC document
February 03, 2022 Filed Feb 7, 2022 18:45 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Exercise / conversionCommon Stock 137 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-007602 · doc4.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.